Sven T Sowa

6PUBLICATIONS
23CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsMolecular targetsNuclear engineering (incl. fuel enrichment and waste processing and storage)Site-based writing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 29, 2026
Replacement soaking for human tankyrase 2 enables studies on substrate analogues and inhibitors.

|Jan 18, 2024
Discovery of 2-amide-3-methylester thiophenes that target SARS-CoV-2 Mac1 and repress coronavirus replication, validating Mac1 as an anti-viral target.

Sarah Wazir, Tomi A O Parviainen, Jessica J Pfannenstiel

|Mar 06, 2023
The Tankyrase Inhibitor OM-153 Demonstrates Antitumor Efficacy and a Therapeutic Window in Mouse Models.

Shoshy A Brinch, Enya Amundsen-Isaksen, Sandra Espada

|Mar 23, 2022
The zinc-binding motif in tankyrases is required for the structural integrity of the catalytic ADP-ribosyltransferase domain.

Sven T Sowa, Lari Lehtiö

|Nov 24, 2021
Assay technologies facilitating drug discovery for ADP-ribosyl writers, readers and erasers.

Tuomo Glumoff, Sven T Sowa, Lari Lehtiö

|Jun 19, 2021
Evaluation of 3- and 4-Phenoxybenzamides as Selective Inhibitors of the Mono-ADP-Ribosyltransferase PARP10.

Patricia Korn, Arno Classen, Sudarshan Murthy

Pageof 1

Frequent Collaborators

6 joint publications

Lari Lehtiö

3 joint publications

Albert Galera-Prat

2 joint publications

Mirko M Maksimainen

1 joint publications

Sudarshan Murthy